Insider Selling: Tabula Rasa HealthCare Inc (TRHC) CEO Sells 8,000 Shares of Stock

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of the stock in a transaction on Thursday, February 7th. The stock was sold at an average price of $52.73, for a total transaction of $421,840.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Tabula Rasa HealthCare stock traded up $1.15 during mid-day trading on Monday, reaching $53.96. The company’s stock had a trading volume of 687,087 shares, compared to its average volume of 361,310. The company has a market cap of $1.08 billion, a P/E ratio of -1,349.00, a price-to-earnings-growth ratio of 3.35 and a beta of 1.79. Tabula Rasa HealthCare Inc has a 12 month low of $28.55 and a 12 month high of $91.16. The company has a current ratio of 0.49, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28.

Several equities research analysts have recently issued reports on the stock. BidaskClub downgraded shares of Tabula Rasa HealthCare from a “sell” rating to a “strong sell” rating in a research report on Saturday. Zacks Investment Research downgraded shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 22nd. Benchmark assumed coverage on shares of Tabula Rasa HealthCare in a research report on Tuesday, January 8th. They set a “buy” rating and a $85.00 price objective for the company. Finally, Piper Jaffray Companies reissued an “overweight” rating and set a $80.00 price objective on shares of Tabula Rasa HealthCare in a research report on Thursday, December 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $82.27.



A number of institutional investors have recently added to or reduced their stakes in TRHC. First Mercantile Trust Co. bought a new position in Tabula Rasa HealthCare in the fourth quarter valued at $39,000. TCI Wealth Advisors Inc. grew its position in Tabula Rasa HealthCare by 1,600.0% in the fourth quarter. TCI Wealth Advisors Inc. now owns 850 shares of the company’s stock valued at $54,000 after purchasing an additional 800 shares in the last quarter. Quantamental Technologies LLC bought a new position in Tabula Rasa HealthCare in the fourth quarter valued at $64,000. Oppenheimer Asset Management Inc. bought a new position in Tabula Rasa HealthCare in the fourth quarter valued at $135,000. Finally, LS Investment Advisors LLC grew its position in Tabula Rasa HealthCare by 19.9% in the fourth quarter. LS Investment Advisors LLC now owns 2,813 shares of the company’s stock valued at $179,000 after purchasing an additional 466 shares in the last quarter. 79.23% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Tabula Rasa HealthCare Inc (TRHC) CEO Sells 8,000 Shares of Stock” was posted by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://dakotafinancialnews.com/2019/02/12/insider-selling-tabula-rasa-healthcare-inc-trhc-ceo-sells-8000-shares-of-stock.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

See Also: What is the Bid-Ask Spread?

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply